PubMed Health⌕ Search

Biomedical subjects

P Owen

Publications and source records attributed to P Owen.

At least 19 recordsLinked to original sources

Fetal size and growth velocity in the prediction of the large for gestational age (LGA) infant in a glucose impaired population.

OBJECTIVES: To evaluate the performances of estimated fetal weight (EFW) and fetal growth velocity (FGV) in the prediction of birth weight>95th centile amongst women with impaired glucose tolerance (IGT); the prediction of neonatal hypoglycaemia was a secondary endpoint. STUDY DESIGN: Two hundred and forty-two consecutive women (61 type 1 diabetes mellitus, 14 type 2 diabetes mellitus, 49 gestational diabetics and 118 with impaired glucose tolerance) receiving routine care at the combined diabetes/antenatal clinic, Jessop Hospital for Women, Sheffield. EFW was routinely calculated at approximately two-week intervals in the third trimester with the last EFW prior to delivery used in the analysis. FGV was calculated from two estimates of fetal weight between 21 and 35 days apart. EFW and FGV were both expressed as standard deviation (Z) scores. RESULTS: The mean gestational age at delivery was 37 weeks (range 26-40 weeks). Sixty-five (27%) infants were of birth weight>95th centile. Mean EFW Z scores were 2.7 and 0.99 for >95th and <95th centile, respectively (p<0.001). Receiver operator characteristics (ROC) curve analysis gave area under the curve 0.8; using a cut-off Z score of 1.7 (=95.5 centile), EFW has sensitivity 80% and specificity 72% in predicting an LGA neonate (likelihood ratios 2.8 and 0.27 for positive and negative test). Mean FGV Z scores were 0.85 and 0.4 for >95th and <95th centile, respectively (p>0.05); ROC curve analysis indicated no discriminatory capacity. Estimates of fetal size and growth performed poorly in the prediction of neonatal hypoglycaemia. CONCLUSION: In routine clinical practice, EFW has limited utility in the prediction of the LGA infant. FGV does not identify the LGA infant. EFW and FGV do not predict neonatal hypoglycaemia.

Anthropometry↗

Management of early pregnancy loss--a complete audit cycle.

This is a complete audit of the management of early pregnancy within Glasgow hospitals using the Royal College of Obstetricians & Gynaecologists (RCOG) Clinical Green Top Guideline 25 as the set standard. The Effective Gynaecology in Glasgow Group (EGGG) developed a document to record the current practice of the management of early pregnancy loss within Glasgow hospitals over a 4-week prospective period. Results were centrally collated and distributed to individual units. All units were formally instructed in the current RCOG guideline and a repeat audit cycle was undertaken to determine any difference in management. There was improvement in all categories analysed, as outlined in Table I. We have demonstrated that a dedicated group can improve clinical management through the audit process.

Abortion, Spontaneous↗

MHC class II, tumour necrosis factor alpha, and lymphotoxin alpha gene haplotype associations with serological subsets of systemic lupus erythematosus.

OBJECTIVE: To conduct a case-control study to investigate whether there are independent tumour necrosis factor alpha (TNFalpha) or lymphotoxin alpha (LTalpha) haplotype associations with SLE or with any of the major serological subsets of SLE. METHODS: 157 patients with SLE were genotyped for HLA-DRB1, HLA-DQB1, TNFalpha, and LTalpha alleles by polymerase chain reaction and compared with 245 normal white controls. For TNFalpha, six single nucleotide polymorphisms (SNPs) at positions -1031, -863, -857, -308, -238, and +488 and for LTalpha three SNPs at positions +720, +365, and +249 were studied to assign six TNFalpha haplotypes (TNF1-6) and four LTalpha haplotypes (LTA1-4). All SLE patients had full serological profiles on serial samples. RESULTS: The most significant association with SLE overall was with HLA-DR3 (p<0.001; odds ratio (OR) = 2.5 (95% confidence interval, 1.6 to 3.8)) and the extended haplotype HLA-DQB1*0201;DRB1*0301;TNF2;LTA2 (p<0.001; OR = 2.3 (1.4 to 3.7)). Associations were strongest in the anti-La positive group (13%) of SLE patients (HLA-DR3, OR = 71 (9 to 539); HLA-DQB1*0201, OR = 35 (5 to 267); TNF2, OR = 10 (2.8 to 36), and LTA2, OR = 4.9 (1.1 to 21)). There was an increase in the HLA-DR2 associated extended haplotype (HLA-DQB1*0602;DRB1*1501;TNF1;LTA1) in patients with anti-Ro in the absence of anti-La (p<0.005; OR = 3.9 (1.5 to 10)). The HLA-DR7 extended haplotype (HLA-DQB1*0303;DRB1*0701/2;TNF5;LTA3) was decreased in SLE overall (p<0.02; OR = 0.2 (0.05 to 0.8)). CONCLUSIONS: The strongest association in this predominantly white population with SLE was between HLA-DR3 and anti-La, which seemed to account for any associations with TNFalpha alleles on an extended DR3 haplotype.

Autoantibodies↗

The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis.

OBJECTIVES: Antibodies recognizing a cyclic citrullinated peptide (anti-CCP) are highly specific for rheumatoid arthritis (RA) but their role in psoriatic arthritis (PsA) remains unclear. The aim of this study was therefore to investigate the prevalence of anti-CCP antibodies in PsA and assess their clinical and genetic associations. METHODS: One hundred and twenty-six patients with PsA, 40 patients with seropositive RA and 40 controls were tested for the presence of anti-CCP antibodies, rheumatoid factor (RF) and the HLA-DRB1 shared epitope. Clinical and radiological data were collected prospectively on all patients and compared between anti-CCP-positive and -negative patients. RESULTS: Seven (5.6%) patients with PsA were positive for anti-CCP antibodies compared with 0% of controls and 97% of patients with seropositive RA. The presence of anti-CCP antibodies in PsA was significantly associated with the HLA-DRB1 shared epitope (P<0.005), erosive disease (P<0.05), number of swollen joints (P<0.02) and DMARD use (P<0.05). CONCLUSIONS: Overall, the increased prevalence of anti-CCP antibodies in this PsA population failed to reach statistical significance. However, when present, they were a marker of disease severity and had RA-linked MHC class II associations. Further studies are needed in a larger population of patients with PsA and appropriate controls to confirm any true association that may be present.

Adult↗

Audit of intrapartum group B streptococcus prophylaxis.

Group B streptococcus is the most frequent cause of severe early onset neonatal infection. For over 3 years our department has employed a risk-factor-based protocol of intra-partum antibiotic prophylaxis. Prophylaxis has been considered adequate if women receive antibiotics more than 4 hours before delivery. This study aims (1) to establish the adequacy of intrapartum prophylaxis in routine clinical practice and (2) to determine whether changing the time interval (from commencement of prophylaxis to delivery) for adequacy from 4 to 2 hours (based on RCOG guidelines) improves the percentage of women receiving adequate prophylaxis. This was an audit against established protocol. Case notes of consecutive deliveries over a 4-week period were reviewed retrospectively. A total of 396 deliveries occurred during the study period. Some 44 women (11%) were eligible for antibiotic prophylaxis. Adequate prophylaxis was achieved in 21 cases (49%). If the time for prophylaxis to be considered adequate was reduced from 4 to 2 h, the number of women receiving adequate prophylaxis increased to 33 (76%). In conclusion, despite the protocol being well established, only half of the eligible women receive adequate intra-partum prophylaxis. Reducing the time interval from 4 to 2 h appreciably increases the number of women receiving adequate prophylaxis, which reduces the necessity of providing neonatal prophylaxis.

Anti-Bacterial Agents↗

Prediction of preterm delivery in twin pregnancy: a prospective, observational study of cervical length and fetal fibronectin testing.

OBJECTIVE: To evaluate prospectively cervical length measurements and fetal fibronectin detection as predictors of spontaneous preterm delivery in an unselected population of twin pregnancies. METHODS: Transvaginal ultrasound assessments of cervical length were performed serially at 18, 24, 28 and 32 weeks' gestation. Receiver-operating characteristic curves were generated at each time point to determine the optimal cut-off for cervical length and rate of change in cervical length in the prediction of preterm delivery (< 35 weeks). A bedside assay for the detection of fetal fibronectin in the maternal vaginal secretions was performed prior to cervical length measurements from 24 weeks. Likelihood ratios (LRs) were used to assess the performance of each test. RESULTS: The spontaneous preterm delivery rate was 16.5% in 91 studied twin pregnancies. A cervical length </= 25 mm at 18 weeks (LR+ 9.7, sensitivity 14.3%) and </= 22 mm at 24 weeks (LR+ 9.6, sensitivity 28.6%) were the best predictors of preterm delivery. A shortening of cervical length >/= 2.5 mm per week between 18 and 28 weeks' gestation also predicted preterm delivery (LR+ 10.8, sensitivity 16.7%). There was no relationship between the detection of fetal fibronectin and preterm delivery. CONCLUSIONS: This study confirms the value of transvaginal ultrasound assessment of cervical length as a predictor of preterm delivery in twin pregnancies. However, the poor sensitivity of this test makes it unsuitable as a single predictor of preterm delivery. Fetal fibronectin testing does not identify twin pregnancies destined to deliver prematurely.

Adult↗

Adherence to published guidelines for the management of menorrhagia in women undergoing second generation endometrial ablation.

Second-generation endometrial ablation techniques provide an effective surgical treatment option for women with menorrhagia. Their ease of use might result in inappropriate surgical treatment without previous medical therapy. We sought to establish local compliance with national guidelines following the recent introduction of second generation ablation techniques into routine practice. We collected data at the time of ablation on the preceding medical management of women undergoing either microwave endometrial ablation or thermal balloon ablation. One hundred and thirty-two consecutive women underwent second-generation endometrial ablation. At least one medical treatment (range 1-5) was used before ablation in 86% of women. The majority (86%) of women undergoing a second-generation endometrial ablation technique received at least one effective medical therapy before surgical intervention, indicating a high level of compliance with published guidelines.

Adult↗

Interleukin 1alpha, interleukin 1beta and interleukin 1 receptor gene polymorphisms in psoriatic arthritis.

OBJECTIVES: To investigate polymorphisms of interleukin (IL) 1alpha, IL-1beta and IL-1 receptor R1 genes in patients with psoriatic arthritis (PsA), their relationship to the age of onset of psoriasis and the pattern of joint involvement. METHODS: One hundred and forty well-characterized patients with PsA were studied. One hundred healthy controls were recruited from primary care. All were genotyped for single-nucleotide polymorphisms in the genes for IL-1alpha (position -889), IL-1beta (position +3953) and IL-1R1 (position +970). The frequencies of the respective variants were compared between patients and controls and in relation to age of onset of psoriasis, to clinical subsets of the disease and to the presence of erosions. RESULTS: All three polymorphisms were in Hardy-Weinberg equilibrium in both patients and controls. The frequency of IL-1alpha -889 CC homozygotes was significantly increased in PsA patients compared with normal controls [58 vs 40%, odds ratio (OR) 2.06, 95%, confidence interval (CI) 1.22-3.47]. The frequency of the IL-1alpha -889 C allele was significantly increased in PsA patients compared with controls (75 vs 65%, OR 1.65, 95% CI 1.11-2.45). In subset analysis there were no other significant differences in allelic frequencies for the IL-1alpha -889 C/T, IL-1beta +3953 C/T and IL-1R1 +970 C/T polymorphisms. CONCLUSIONS: The IL-1 gene complex may play a role in the development of PsA and/or psoriasis or act as a marker for other genes on chromosome 2q12 to 2q13.

Adult↗

Is there a relationship between estimated fetal weight and umbilical artery Doppler impedance indices?

OBJECTIVE: To establish whether there is a relationship between estimated fetal weight (EFW) and umbilical artery Doppler waveform impedance indices in the third trimester. METHODS: The pulsatility index (PI) and S/D (systolic/diastolic) ratio were obtained together with the EFW from 274 low-risk pregnancies. Measurements were made at fortnightly intervals from 30 weeks' gestation until delivery. A relationship between the two impedance indices and EFW was sought at gestational age ranges of 30-32, 33-35, 36-38 and 39-41 weeks. RESULTS: There were 918 pairs of PI (with S/D) and EFW available for analysis. The mean of the impedance indices decreased with advancing gestational age as expected. There was no clinically relevant correlation between impedance indices and EFW within any of the gestational age ranges. CONCLUSION: Impedance indices from the umbilical artery Doppler waveform decrease with advancing gestational age due, at least partially, to expansion of the placental vascular tree. Within narrow gestational age ranges in the third trimester, there is no meaningful correlation between fetal weight and impedance indices. It is therefore not necessary to adjust umbilical artery Doppler impedance indices to account for fetal size.

Embryonic and Fetal Development↗

Multivariable analysis of tests for the diagnosis of intrauterine growth restriction.

OBJECTIVES: To describe how data from antenatal fetal ultrasound biometry, amniotic fluid index and umbilical artery Doppler can be appropriately combined using multivariable models and to investigate how the addition of these ultrasound parameters influences the ability to predict intrauterine growth restriction (IUGR). METHODS: This was a prospective cohort study involving 274 low-risk pregnancies undergoing serial ultrasound examination at predetermined intervals. Standard deviation (Z) scores of the last values for fetal abdominal area (FAA), growth velocity of the FAA, amniotic fluid index (AFI) and umbilical artery Doppler pulsatility index prior to delivery were calculated for 260 fetuses. Customized estimated fetal weight (cEFW) centiles were also calculated using the last EFW before delivery after adjustment for fetal gender, gestational age, birth order and maternal weight, height and ethnic origin. Following delivery the neonatal ponderal index was calculated and centile position obtained. A neonatal ponderal index <25(th) centile served as the main outcome measure for diagnosis of IUGR. Logistic regression analysis was used to delineate the predictive value of the three fetal growth tests FAA, FAA growth velocity and cEFW and the additional values of AFI and pulsatility index of the umbilical artery. RESULTS: The areas under the receiver-operating characteristics (ROC) curves (95% confidence interval) for FAA, FAA growth velocity and cEFW alone were 0.819 (0.748-0.891), 0.784 (0.699-0.869) and 0.74 (0.643-0.837), respectively, in the prediction of a neonatal ponderal index <25(th) centile. The addition of both the AFI and pulsatility index to FAA, FAA growth velocity and cEFW generated small increases in the areas, to 0.831 (0.758-0.904), 0.817 (0.735-0.899) and 0.766 (0.672-0.859), respectively. These improvements in diagnostic prediction were not statistically significant. CONCLUSIONS: The addition of AFI and umbilical artery pulsatility index to the fetal biometry parameters did not significantly increase the ROC areas in the study population. The approach applied in this study is useful in the context of hypothesis generation. Further studies using larger data sets and other predictors should be carried out using the analytical techniques outlined in this paper to determine the contribution of various antenatal tests in the prediction of IUGR.

Amniotic Fluid↗

Is there a relationship between fetal weight and amniotic fluid index?

OBJECTIVE: To establish whether there is a relationship between the amniotic fluid index and estimated fetal weight in the third trimester. The presence of a relationship would require adjustment of amniotic fluid index to take account of estimated fetal weight with potential improvement in its prediction of adverse perinatal outcomes. METHODS: Paired measurements of amniotic fluid index and estimated fetal weight from 274 low-risk pregnancies enrolled in a longitudinal study of fetal growth. Measurements were made at fortnightly intervals from 30 weeks' gestation until delivery. A relationship between amniotic fluid index and estimated fetal weight was sought at gestational age week intervals of 30-32, 33-35, 36-38 and 39-41. RESULTS: One thousand and three pairs of measurements of amniotic fluid index and estimated fetal weight were available for analysis. Mean amniotic fluid index decreased towards term as expected. There was no correlation between amniotic fluid index and estimated fetal weight. Furthermore, there was no correlation between amniotic fluid index and estimated fetal weight at any of the gestational age intervals. CONCLUSIONS: There is no clinically relevant correlation between amniotic fluid index and estimated fetal weight. It should remain clinical practice to take account of gestational age when interpreting amniotic fluid index but it is not necessary to make adjustments for estimated fetal weight.

Adult↗

Interval between fetal measurements in predicting growth restriction.

OBJECTIVE: To determine the influence of the interval between fetal measurements on performance of fetal growth velocity for predicting infants with anthropometric features of fetal growth restriction (FGR). METHODS: Two hundred seventy-four low-risk women had serial fetal biometry at scheduled intervals. Growth velocity of the fetal abdominal area for each was calculated with 2-, 4-, and 6-week scan intervals in which the second measurement was the last scan before delivery. Fetal abdominal area velocity over a 4-week interval in the early third trimester also was included. Fetal growth restriction was defined as skinfold thickness under the tenth percentile, ponderal index under the 25th percentile, midarm circumference-to-occipitofrontal circumference ratio of under -1 standard deviation (SD). Test performance was expressed as likelihood ratios with 95% confidence intervals (CI). RESULTS: Fetal abdominal area velocity calculated over a 4-week interval predicted FGR with a likelihood ratio of 10.4 (95% CI 3.9, 26) for skinfold thickness; 9.5 (95% CI 4.6, 19) for ponderal index; and 4.7 (2.3, 8.4) for midarm circumference-to-occipitofrontal circumference ratio. Intermeasurement intervals of 6 weeks had a likelihood ratio of 8.5 (95% CI 4, 17) for skinfold thickness; 7.5 (95% CI 3.4, 16.1) for ponderal index; and 14 (6.7, 28) for midarm circumference-to-occipitofrontal circumference ratio. The likelihood ratios for the 2-week interval and the early third trimester 4-week interval were all less than 5. CONCLUSION: Four- and 6-week measurement intervals were useful for predicting infants with FGR and were superior to a 2-week interval. Fetal growth velocity is influenced by proximity of the last fetal measurement to date of delivery, which adversely affects clinical use of growth velocity for predicting FGR.

Adult↗

Antigen 43, the major phase-variable protein of the Escherichia coli outer membrane, can exist as a family of proteins encoded by multiple alleles.

agn43 encodes a major phase-variable outer-membrane protein, antigen 43 (Ag43), involved in autoaggregation of Escherichia coli cells. The gene is present in single copy on the chromosome of E. coli K-12. In contrast, Southern hybridization and gene inactivation studies demonstrate that control producer strain E. coli ML308-225 possesses duplicate copies of agn43 (agn43A and agn43B). Construction and analyses of single and double knockout mutants clearly show that both alleles are capable of expressing antigen in a phase-variable manner, with observed differences in the ON<-->OFF switch frequencies appearing to favour expression of Ag43B under conditions of normal laboratory growth. Comparative analysis of agn43A and agn43B gene sequences revealed 98% identity at the nucleotide and predicted protein levels, with differences in the protein sequence of the surface-expressed alpha(43) subunit altering the surface probability of one of the predicted epitopes. Analysis of a panel of enteropathogenic E. coli strains by Southern hybridization using agn43-specific gene probes provided strong evidence for the presence of varying numbers of agn43 alleles within clinical isolates. Taken together, the results indicate the presence of a family of distinct Ag43 proteins encoded by multiple chromosomal alleles.

Adhesins, Bacterial↗

The fibrinogen-binding protein (FgBP) of Streptococcus equi subsp. equi additionally binds IgG and contributes to virulence in a mouse model.

The major cell-wall-associated protein of the equine pathogen Streptococcus equi subsp. equi is an M-like fibrinogen-binding protein (FgBP) which binds equine fibrinogen (Fg) avidly, through residues located at the extreme N-terminus of the molecule. In this study, it is shown that FgBP additionally binds equine IgG-Fc. When tested against polyclonal IgG from ten other animal species, it was found that FgBP binds human, rabbit, pig and cat IgG, but does not bind mouse, rat, goat, sheep, cow or chicken IgG. Through the use of a panel of recombinant FgBP truncates containing defined deletions of sequence, it was shown that residues in the central regions of FgBP are important in IgG binding. An fbp knockout mutant which does not express FgBP on the cell surface was also constructed. Mutant cells failed to autoaggregate, bound no detectable equine Fg or IgG-Fc, were rapidly killed in horse blood, and showed greatly decreased virulence in a mouse model. Results suggest that FgBP is the major surface structure responsible for binding either Fg or IgG, that the molecule has pronounced antiphagocytic properties, and that it is a likely factor contributing to the virulence of wild-type S. equi subsp. equi.

Animals↗

A complete audit cycle of intrapartum group B streptococcus prophylaxis.

INTRODUCTION: Group B Streptococcus (GBS) colonises the intestines of approximately one third of women and can result in intermittent colonisation of the vagina. The principal route of neonatal infection is from the vagina during delivery which can cause morbidity and mortality in the neonate. We recently introduced a protocol of intrapartum prophylaxis based on recognised risk factors. OBJECTIVE: To complete an audit cycle to determine the adequacy of intrapartum antibiotic prophylaxis for women with recognised risk factors for neonatal GBS infection, to make changes to the indications for prophylaxis and to highlight and rectify any deficiencies in practice. METHODS: Women identified with risk factors for neonatal GBS were treated with a regimen of intravenous benzylpenicillin or clindamycin. Adequate prophylaxis was achieved if the women received antibiotics more than four hours prior to delivery. The case notes of all deliveries over a four-week period were reviewed in both the initial audit and the re-audit. RESULTS: Three hundred and fifty nine deliveries occurred during the initial study period. Thirty seven (10.3%) women were identified with risk factors but adequate prophylaxis was provided to only 32%. Difficulty in providing adequate prophylaxis to women with intrapartum maternal pyrexia due to time constraints and an unanticipated increase in the number of neonates of 35 to 37 weeks gestation receiving postnatal intravenous antibiotics necessitated changes to the indications for prophylaxis. During the re-audit there were 378 deliveries with 49 (13%) women identified with risk factors and adequate prophylaxis was achieved in 42% of women. CONCLUSION: Despite changes to the protocol and circulation of the results to medical and midwifery staff, the percentage of women receiving adequate prophylaxis is low. Areas for further improvement include greater awareness of the indications for prophylaxis through education and better documentation of risk factors present before labour. Despite the benefits of adopting a protocol of intrapartum prophylaxis it is important to recognise its practical limitations and to continue to be vigilant in identifying and treating neonates whose mothers have not received adequate treatment.

Antibiotic Prophylaxis↗

Neither the A- nor B-repeat regions of the fibrinogen-binding protein of Streptococcus equi subsp. equi are essential for fibrinogen binding.

The major cell wall-associated protein (FgBP) of Streptococcus equi subsp. equi possesses two internal blocks of repeated sequence (A and B) and binds horse fibrinogen (Fg) avidly through residues located in the N-terminal half of the molecule. In the present study, we investigated the roles of the two repeats blocks in Fg binding through construction of recombinant FgBP proteins containing defined internal deletions of sequence. Ligand binding experiments clearly showed that neither repeat is essential for Fg binding. However, residues within the B repeats seem to play a major role in the aberrant mobility observed for FgBP following sodium dodecyl sulfate polyacrylamide gel electrophoresis.

Animals↗